Private healthcare service provider Aster DM Healthcare (India) is looking to strengthen its foothold in the northern and western regions of the country. The company is exploring inorganic opportunities to pursue its growth plans. Aster is looking to fund this path through internal accruals, which have been bolstered by the sale of the Gulf Cooperation Council (GCC) business. The company is also in discussion with some private equity players to partner with.
Over the next two-three years, the company seeks to take the total tally of beds in India to more than 6,000, which will include the upcoming Aster Capital in Trivandrum with 350-plus beds in the first phase by FY26, as well as Aster MIMS Kasargod with 200-plus beds. Currently at 4,800 beds, Aster is planning an additional infusion of 1,500 beds for the next three years entailing an outlay of Rs 850-900 crore. It also expects to add bed capacity to existing hospitals in Medcity, MIMS Kannur by about 100 beds each and Aster Whitefield with 159 beds.
Aster is present in five states in the south through 19 hospitals, 13 clinics, 226 pharmacies and 251 patient experience centres. Its hospitals in India are in Kochi, Kolhapur, Kozhikode, Kottakkal, Bengaluru and Hyderabad. With a presence in Hyderabad, the company sees Maharashtra, and Pune as highly attractive, as well as Uttar Pradesh in light of the recent trend of North-based groups venturing into the region.
Last year, the company announced that its subsidiary would sell its stake in Aster DM Healthcare FZC to Alpha GCC to fund its growth.
